Related Experiment Video
Updated: May 28, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Ligand-Receptor Interaction Combined with Histopathology Improves Glioma Prognostic Model
Lun Gao1,2, Rui Zhang3, Xiaonan Zhu1
1Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Biomedicines
|May 27, 2026
Summary
This study introduces a new method combining cell communication analysis and AI-based pathology to predict glioblastoma patient survival. It identifies key molecular interactions and histological features for improved glioblastoma risk stratification.
Area of Science:
- Oncology
- Bioinformatics
- Computational Pathology
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
- Current diagnostic and prognostic methods for GBM are insufficient.
- There is a critical need for integrated strategies to enhance patient outcomes.
Purpose of the Study:
- To develop a multi-modal framework for glioblastoma risk stratification.
- To identify key ligand-receptor interactions and histopathological features impacting patient survival.
- To integrate interactomics and deep learning-based pathomics for improved prognostic accuracy.
Main Methods:
- Analysis of ligand-receptor (L-R) interactions in TCGA-GBM transcriptomes using BulkSignaL-R.
- Validation of spatial expression patterns with single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics.
- Omics-guided identification of prognostic histopathological features from H&E-stained sections using machine learning.
- Development of a deep learning model for risk stratification based on histological features.
Main Results:
- Four pivotal L-R pairs (LTB-CD40, VEGFA-ITGB1, FN1-COL13A1, TGM2-ITGB1) were identified, forming an independent prognostic risk model.
- The risk score was significantly associated with Overall Survival (OS) (HR = 1.67, p < 0.001).
- High-risk patients showed distinct molecular signatures (e.g., CALN1 mutations, Notch/interferon-γ signaling).
- A deep learning model accurately stratified risk groups based on histological features (AUC = 0.750).
Conclusions:
- A novel multi-modal framework integrating L-R interactomics and deep learning pathomics was developed.
- This approach elucidates the molecular and spatial landscape of glioma intercellular communication.
- The framework provides a robust methodological foundation for glioblastoma risk stratification and improved patient management.
